nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—GABRA3—Graves' disease	0.826	1	CbGaD
Estazolam—Neuritis—Methimazole—Graves' disease	0.00568	0.0909	CcSEcCtD
Estazolam—Neuritis—Propylthiouracil—Graves' disease	0.00483	0.0773	CcSEcCtD
Estazolam—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.00441	0.0468	CbGpPWpGaD
Estazolam—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00434	0.0461	CbGpPWpGaD
Estazolam—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00371	0.0394	CbGpPWpGaD
Estazolam—Lymphadenopathy—Methimazole—Graves' disease	0.00361	0.0578	CcSEcCtD
Estazolam—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.0036	0.0383	CbGpPWpGaD
Estazolam—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00348	0.037	CbGpPWpGaD
Estazolam—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00346	0.0367	CbGpPWpGaD
Estazolam—GABRR1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00344	0.0365	CbGpPWpGaD
Estazolam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00339	0.036	CbGpPWpGaD
Estazolam—GABRR2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00328	0.0348	CbGpPWpGaD
Estazolam—Lymphadenopathy—Propylthiouracil—Graves' disease	0.00307	0.0491	CcSEcCtD
Estazolam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00297	0.0315	CbGpPWpGaD
Estazolam—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0027	0.0287	CbGpPWpGaD
Estazolam—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00266	0.0282	CbGpPWpGaD
Estazolam—Neuropathy peripheral—Methimazole—Graves' disease	0.00233	0.0372	CcSEcCtD
Estazolam—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00227	0.0241	CbGpPWpGaD
Estazolam—Agranulocytosis—Methimazole—Graves' disease	0.00222	0.0354	CcSEcCtD
Estazolam—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00221	0.0234	CbGpPWpGaD
Estazolam—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00213	0.0226	CbGpPWpGaD
Estazolam—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00212	0.0225	CbGpPWpGaD
Estazolam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00208	0.0221	CbGpPWpGaD
Estazolam—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00198	0.0317	CcSEcCtD
Estazolam—Agranulocytosis—Propylthiouracil—Graves' disease	0.00188	0.0301	CcSEcCtD
Estazolam—GABRR1—GABA receptor activation—GABRA3—Graves' disease	0.00182	0.0194	CbGpPWpGaD
Estazolam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00182	0.0193	CbGpPWpGaD
Estazolam—GABRR2—GABA receptor activation—GABRA3—Graves' disease	0.00174	0.0185	CbGpPWpGaD
Estazolam—Leukopenia—Methimazole—Graves' disease	0.00166	0.0266	CcSEcCtD
Estazolam—Arthralgia—Methimazole—Graves' disease	0.00158	0.0253	CcSEcCtD
Estazolam—Myalgia—Methimazole—Graves' disease	0.00158	0.0253	CcSEcCtD
Estazolam—Oedema—Methimazole—Graves' disease	0.00151	0.0242	CcSEcCtD
Estazolam—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.00143	0.0152	CbGpPWpGaD
Estazolam—Leukopenia—Propylthiouracil—Graves' disease	0.00141	0.0226	CcSEcCtD
Estazolam—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.00141	0.015	CbGpPWpGaD
Estazolam—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00138	0.0221	CcSEcCtD
Estazolam—Paraesthesia—Methimazole—Graves' disease	0.00136	0.0218	CcSEcCtD
Estazolam—Somnolence—Methimazole—Graves' disease	0.00135	0.0215	CcSEcCtD
Estazolam—Myalgia—Propylthiouracil—Graves' disease	0.00134	0.0215	CcSEcCtD
Estazolam—Arthralgia—Propylthiouracil—Graves' disease	0.00134	0.0215	CcSEcCtD
Estazolam—Dyspepsia—Methimazole—Graves' disease	0.00133	0.0213	CcSEcCtD
Estazolam—Oedema—Propylthiouracil—Graves' disease	0.00129	0.0206	CcSEcCtD
Estazolam—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.00121	0.0128	CbGpPWpGaD
Estazolam—Urticaria—Methimazole—Graves' disease	0.0012	0.0192	CcSEcCtD
Estazolam—Body temperature increased—Methimazole—Graves' disease	0.0012	0.0192	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00117	0.0188	CcSEcCtD
Estazolam—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.00117	0.0124	CbGpPWpGaD
Estazolam—Paraesthesia—Propylthiouracil—Graves' disease	0.00116	0.0185	CcSEcCtD
Estazolam—Somnolence—Propylthiouracil—Graves' disease	0.00114	0.0183	CcSEcCtD
Estazolam—Dyspepsia—Propylthiouracil—Graves' disease	0.00113	0.0181	CcSEcCtD
Estazolam—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.00113	0.012	CbGpPWpGaD
Estazolam—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.00112	0.0119	CbGpPWpGaD
Estazolam—GABRR3—eye—Graves' disease	0.00112	0.129	CbGeAlD
Estazolam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.0011	0.0117	CbGpPWpGaD
Estazolam—Pruritus—Methimazole—Graves' disease	0.00107	0.0171	CcSEcCtD
Estazolam—Urticaria—Propylthiouracil—Graves' disease	0.00102	0.0164	CcSEcCtD
Estazolam—Body temperature increased—Propylthiouracil—Graves' disease	0.00102	0.0163	CcSEcCtD
Estazolam—GABRR2—eye—Graves' disease	0.000969	0.112	CbGeAlD
Estazolam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000964	0.0102	CbGpPWpGaD
Estazolam—Vomiting—Methimazole—Graves' disease	0.000963	0.0154	CcSEcCtD
Estazolam—Rash—Methimazole—Graves' disease	0.000955	0.0153	CcSEcCtD
Estazolam—Dermatitis—Methimazole—Graves' disease	0.000954	0.0153	CcSEcCtD
Estazolam—Headache—Methimazole—Graves' disease	0.000948	0.0152	CcSEcCtD
Estazolam—GABRR1—eye—Graves' disease	0.000932	0.108	CbGeAlD
Estazolam—Pruritus—Propylthiouracil—Graves' disease	0.000911	0.0146	CcSEcCtD
Estazolam—Nausea—Methimazole—Graves' disease	0.000899	0.0144	CcSEcCtD
Estazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000838	0.0089	CbGpPWpGaD
Estazolam—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.000835	0.00887	CbGpPWpGaD
Estazolam—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000823	0.00874	CbGpPWpGaD
Estazolam—Vomiting—Propylthiouracil—Graves' disease	0.000819	0.0131	CcSEcCtD
Estazolam—Rash—Propylthiouracil—Graves' disease	0.000812	0.013	CcSEcCtD
Estazolam—Dermatitis—Propylthiouracil—Graves' disease	0.000811	0.013	CcSEcCtD
Estazolam—Headache—Propylthiouracil—Graves' disease	0.000806	0.0129	CcSEcCtD
Estazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.0008	0.00849	CbGpPWpGaD
Estazolam—Nausea—Propylthiouracil—Graves' disease	0.000765	0.0122	CcSEcCtD
Estazolam—GABRR1—Ion channel transport—GABRA3—Graves' disease	0.000746	0.00792	CbGpPWpGaD
Estazolam—GABRG3—pituitary gland—Graves' disease	0.000726	0.0842	CbGeAlD
Estazolam—GABRR2—Ion channel transport—GABRA3—Graves' disease	0.000711	0.00756	CbGpPWpGaD
Estazolam—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.000703	0.00747	CbGpPWpGaD
Estazolam—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000683	0.00725	CbGpPWpGaD
Estazolam—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.000659	0.007	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000658	0.00699	CbGpPWpGaD
Estazolam—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000655	0.00696	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000649	0.00689	CbGpPWpGaD
Estazolam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000643	0.00683	CbGpPWpGaD
Estazolam—Chlordiazepoxide—GABRA3—Graves' disease	0.000642	0.0762	CrCbGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00063	0.00669	CbGpPWpGaD
Estazolam—Clonazepam—GABRA3—Graves' disease	0.00062	0.0736	CrCbGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000601	0.00639	CbGpPWpGaD
Estazolam—Clorazepate—GABRA3—Graves' disease	0.000601	0.0712	CrCbGaD
Estazolam—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.000586	0.00622	CbGpPWpGaD
Estazolam—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.000577	0.00613	CbGpPWpGaD
Estazolam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000562	0.00597	CbGpPWpGaD
Estazolam—GABRB1—pituitary gland—Graves' disease	0.000561	0.0651	CbGeAlD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000554	0.00589	CbGpPWpGaD
Estazolam—Alprazolam—GABRA3—Graves' disease	0.000544	0.0645	CrCbGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000538	0.00572	CbGpPWpGaD
Estazolam—Cinolazepam—GABRA3—Graves' disease	0.00053	0.0629	CrCbGaD
Estazolam—Quazepam—GABRA3—Graves' disease	0.000527	0.0625	CrCbGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00052	0.00552	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000516	0.00548	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000507	0.00538	CbGpPWpGaD
Estazolam—GABRP—pituitary gland—Graves' disease	0.000503	0.0583	CbGeAlD
Estazolam—Flunitrazepam—GABRA3—Graves' disease	0.000498	0.0591	CrCbGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000495	0.00526	CbGpPWpGaD
Estazolam—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000493	0.00524	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000488	0.00518	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—GABRA3—Graves' disease	0.000483	0.00513	CbGpPWpGaD
Estazolam—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000479	0.00509	CbGpPWpGaD
Estazolam—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000462	0.00491	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—GABRA3—Graves' disease	0.000461	0.00489	CbGpPWpGaD
Estazolam—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000459	0.00488	CbGpPWpGaD
Estazolam—Halazepam—GABRA3—Graves' disease	0.000453	0.0537	CrCbGaD
Estazolam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000451	0.00479	CbGpPWpGaD
Estazolam—Nitrazepam—GABRA3—Graves' disease	0.00045	0.0533	CrCbGaD
Estazolam—GABRA3—thyroid gland—Graves' disease	0.000448	0.0519	CbGeAlD
Estazolam—Adinazolam—GABRA3—Graves' disease	0.000443	0.0526	CrCbGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000443	0.00471	CbGpPWpGaD
Estazolam—Fludiazepam—GABRA3—Graves' disease	0.000439	0.0521	CrCbGaD
Estazolam—GABRB3—eye—Graves' disease	0.000438	0.0508	CbGeAlD
Estazolam—Prazepam—GABRA3—Graves' disease	0.000429	0.0508	CrCbGaD
Estazolam—GABRG2—pituitary gland—Graves' disease	0.000424	0.0491	CbGeAlD
Estazolam—GABRB3—connective tissue—Graves' disease	0.000422	0.049	CbGeAlD
Estazolam—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000417	0.00443	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000405	0.0043	CbGpPWpGaD
Estazolam—Flurazepam—GABRA3—Graves' disease	0.0004	0.0474	CrCbGaD
Estazolam—Triazolam—GABRA3—Graves' disease	0.000399	0.0473	CrCbGaD
Estazolam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000394	0.00419	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000391	0.00415	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000388	0.00412	CbGpPWpGaD
Estazolam—Oxazepam—GABRA3—Graves' disease	0.000387	0.0459	CrCbGaD
Estazolam—GABRA2—adipose tissue—Graves' disease	0.000386	0.0447	CbGeAlD
Estazolam—GABRE—pituitary gland—Graves' disease	0.000384	0.0445	CbGeAlD
Estazolam—GABRE—adipose tissue—Graves' disease	0.000382	0.0443	CbGeAlD
Estazolam—Temazepam—GABRA3—Graves' disease	0.000382	0.0453	CrCbGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000381	0.00405	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—GABRA3—Graves' disease	0.000379	0.00403	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000374	0.00397	CbGpPWpGaD
Estazolam—Midazolam—GABRA3—Graves' disease	0.000371	0.0439	CrCbGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000333	0.00354	CbGpPWpGaD
Estazolam—GABRE—thyroid gland—Graves' disease	0.000331	0.0384	CbGeAlD
Estazolam—GABRB3—pituitary gland—Graves' disease	0.000325	0.0377	CbGeAlD
Estazolam—GABRB2—Neuronal System—GABRA3—Graves' disease	0.000319	0.00339	CbGpPWpGaD
Estazolam—Diazepam—GABRA3—Graves' disease	0.000318	0.0377	CrCbGaD
Estazolam—GABRA5—Neuronal System—GABRA3—Graves' disease	0.00031	0.00329	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—GABRA3—Graves' disease	0.000299	0.00318	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000297	0.00316	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000292	0.0031	CbGpPWpGaD
Estazolam—GABRB3—thyroid gland—Graves' disease	0.000281	0.0325	CbGeAlD
Estazolam—GABRR1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00026	0.00276	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000255	0.00271	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000248	0.00263	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000204	0.00217	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000201	0.00213	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000172	0.00182	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000167	0.00177	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000161	0.00171	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00016	0.0017	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000157	0.00167	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000137	0.00146	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	7.98e-05	0.000847	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	5.79e-05	0.000615	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GC—Graves' disease	2.14e-05	0.000227	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.62e-05	0.000172	CbGpPWpGaD
